356 related articles for article (PubMed ID: 25170920)
1. Lectin-like oxidized LDL receptor-1 is an enhancer of tumor angiogenesis in human prostate cancer cells.
González-Chavarría I; Cerro RP; Parra NP; Sandoval FA; Zuñiga FA; Omazábal VA; Lamperti LI; Jiménez SP; Fernandez EA; Gutiérrez NA; Rodriguez FS; Onate SA; Sánchez O; Vera JC; Toledo JR
PLoS One; 2014; 9(8):e106219. PubMed ID: 25170920
[TBL] [Abstract][Full Text] [Related]
2. LOX-1 activation by oxLDL triggers an epithelial mesenchymal transition and promotes tumorigenic potential in prostate cancer cells.
González-Chavarría I; Fernandez E; Gutierrez N; González-Horta EE; Sandoval F; Cifuentes P; Castillo C; Cerro R; Sanchez O; Toledo JR
Cancer Lett; 2018 Feb; 414():34-43. PubMed ID: 29107109
[TBL] [Abstract][Full Text] [Related]
3. LOX-1 Activation by oxLDL Induces AR and AR-V7 Expression via NF-κB and STAT3 Signaling Pathways Reducing Enzalutamide Cytotoxic Effects.
Duprat F; Robles C; Castillo MP; Rivas Y; Mondaca M; Jara N; Roa F; Bertinat R; Toledo J; Paz C; González-Chavarría I
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982155
[TBL] [Abstract][Full Text] [Related]
4. Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.
Hossain E; Ota A; Karnan S; Damdindorj L; Takahashi M; Konishi Y; Konishi H; Hosokawa Y
Toxicol Appl Pharmacol; 2013 Dec; 273(3):651-8. PubMed ID: 24145059
[TBL] [Abstract][Full Text] [Related]
5. LOX-1 receptor: A potential link in atherosclerosis and cancer.
Balzan S; Lubrano V
Life Sci; 2018 Apr; 198():79-86. PubMed ID: 29462603
[TBL] [Abstract][Full Text] [Related]
6. LOX-1-dependent transcriptional regulation in response to oxidized LDL treatment of human aortic endothelial cells.
Mattaliano MD; Huard C; Cao W; Hill AA; Zhong W; Martinez RV; Harnish DC; Paulsen JE; Shih HH
Am J Physiol Cell Physiol; 2009 Jun; 296(6):C1329-37. PubMed ID: 19279231
[TBL] [Abstract][Full Text] [Related]
7. Negative feedback regulation between microRNA let-7g and the oxLDL receptor LOX-1.
Chen KC; Hsieh IC; Hsi E; Wang YS; Dai CY; Chou WW; Juo SH
J Cell Sci; 2011 Dec; 124(Pt 23):4115-24. PubMed ID: 22135361
[TBL] [Abstract][Full Text] [Related]
8. Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.
Lee WJ; Ou HC; Hsu WC; Chou MM; Tseng JJ; Hsu SL; Tsai KL; Sheu WH
J Vasc Surg; 2010 Nov; 52(5):1290-300. PubMed ID: 20692795
[TBL] [Abstract][Full Text] [Related]
9. Potential pathological roles for oxidized low-density lipoprotein and scavenger receptors SR-AI, CD36, and LOX-1 in aortic valve stenosis.
Syväranta S; Alanne-Kinnunen M; Oörni K; Oksjoki R; Kupari M; Kovanen PT; Helske-Suihko S
Atherosclerosis; 2014 Aug; 235(2):398-407. PubMed ID: 24929820
[TBL] [Abstract][Full Text] [Related]
10. ROCK2 associates with lectin-like oxidized LDL receptor-1 and mediates oxidized LDL-induced IL-8 production.
Mattaliano MD; Wooters J; Shih HH; Paulsen JE
Am J Physiol Cell Physiol; 2010 May; 298(5):C1180-7. PubMed ID: 20181930
[TBL] [Abstract][Full Text] [Related]
11. Angiogenesis is a link between atherosclerosis and tumorigenesis: role of LOX-1.
Jiang J; Yan M; Mehta JL; Hu C
Cardiovasc Drugs Ther; 2011 Oct; 25(5):461-8. PubMed ID: 21968594
[TBL] [Abstract][Full Text] [Related]
12. "Affimer" synthetic protein scaffolds block oxidized LDL binding to the LOX-1 scavenger receptor and inhibit ERK1/2 activation.
Roper BWR; Tiede C; Abdul-Zani I; Cuthbert GA; Jade D; Al-Aufi A; Critchley WR; Saikia Q; Homer-Vanniasinkam S; Sawamura T; McPherson MJ; Harrison MA; Tomlinson DC; Ponnambalam S
J Biol Chem; 2023 Nov; 299(11):105325. PubMed ID: 37805141
[TBL] [Abstract][Full Text] [Related]
13. Palmitic acid enhances lectin-like oxidized LDL receptor (LOX-1) expression and promotes uptake of oxidized LDL in macrophage cells.
Ishiyama J; Taguchi R; Yamamoto A; Murakami K
Atherosclerosis; 2010 Mar; 209(1):118-24. PubMed ID: 19782984
[TBL] [Abstract][Full Text] [Related]
14. Lipopolysaccharide augments the uptake of oxidized LDL by up-regulating lectin-like oxidized LDL receptor-1 in macrophages.
Hossain E; Ota A; Karnan S; Takahashi M; Mannan SB; Konishi H; Hosokawa Y
Mol Cell Biochem; 2015 Feb; 400(1-2):29-40. PubMed ID: 25348362
[TBL] [Abstract][Full Text] [Related]
15. Mediation of electronegative low-density lipoprotein signaling by LOX-1: a possible mechanism of endothelial apoptosis.
Lu J; Yang JH; Burns AR; Chen HH; Tang D; Walterscheid JP; Suzuki S; Yang CY; Sawamura T; Chen CH
Circ Res; 2009 Mar; 104(5):619-27. PubMed ID: 19150883
[TBL] [Abstract][Full Text] [Related]
16. Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels: role of the Oct-1/SIRT1 and ERK1/2 pathways.
Akhmedov A; Camici GG; Reiner MF; Bonetti NR; Costantino S; Holy EW; Spescha RD; Stivala S; Schaub Clerigué A; Speer T; Breitenstein A; Manz J; Lohmann C; Paneni F; Beer JH; Lüscher TF
Cardiovasc Res; 2017 Apr; 113(5):498-507. PubMed ID: 28199510
[TBL] [Abstract][Full Text] [Related]
17. Decreased lectin-like oxidized LDL receptor 1 (LOX-1) and low Nrf2 activation in placenta are involved in preeclampsia.
Chigusa Y; Tatsumi K; Kondoh E; Fujita K; Nishimura F; Mogami H; Konishi I
J Clin Endocrinol Metab; 2012 Oct; 97(10):E1862-70. PubMed ID: 22791762
[TBL] [Abstract][Full Text] [Related]
18. Varenicline enhances oxidized LDL uptake by increasing expression of LOX-1 and CD36 scavenger receptors through α
Kanaoka Y; Koga M; Sugiyama K; Ohishi K; Kataoka Y; Yamauchi A
Toxicology; 2017 Apr; 380():62-71. PubMed ID: 28202387
[TBL] [Abstract][Full Text] [Related]
19. FOXA1 promotes prostate cancer angiogenesis by inducing multiple pro-angiogenic factors expression.
Su Y; Zhang Y; Zhao J; Zhou W; Wang W; Han B; Wang X
J Cancer Res Clin Oncol; 2021 Nov; 147(11):3225-3243. PubMed ID: 34258652
[TBL] [Abstract][Full Text] [Related]
20. Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1.
Cimmino G; Cirillo P; Conte S; Pellegrino G; Barra G; Maresca L; Morello A; Calì G; Loffredo F; De Palma R; Arena G; Sawamura T; Ambrosio G; Golino P
Cardiovasc Res; 2020 May; 116(6):1125-1135. PubMed ID: 31504248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
